1. Taiwan Centers for Disease Control. COVID-19 (SARS-CoV2 Infection) Tracker. Available from: https://www.cdc.gov.tw/En. [Last accessed on 2022 May 19].
2. American Academy of Dermatology Guidance on the Use of Medications during COVID-19 Outbreak; 2020. Available from: https://assets.ctfassets.net/1ny4yoiyrqia/PicgNuD0IpYd9MSOwab47/2461e6c12cd88953632a13cd68952b71/Guidance_on_medications__10-12-20.pdf. [Last accessed on 2022 May 19].
3. American College of Rheumatology guidance for the management of rheumatic disease in adult patients during the COVID-19 pandemic: Version 3;Mikuls;Arthritis Rheumatol,2021
4. National Institute for Health and Care Excellence: Guidelines. COVID-19 Rapid Guideline: Rheumatological Autoimmune, Inflammatory and Metabolic Bone Disorders. London: National Institute for Health and Care Excellence (NICE); 2021.
5. National Institute for Health and Care Excellence: Guidelines. COVID-19 Rapid Guideline: Dermatological Conditions Treated with Drugs Affecting the Immune Response. London: National Institute for Health and Care Excellence (NICE); 2021.